ASTRAL-1: High SVR12 with sofosbuvir/velpatasvir combo for HCV

SAN FRANCISCO – Once-daily treatment with fixed-dose combination sofosbuvir/velpatasvir for 12 weeks was well tolerated and resulted in high sustained virologic response rates in hepatitis C–infected...